ResMed | RMD - Nettoeinkommen

Aktienkurs
209.40
Täglich Wechseln
-0.24 -0.11%
Monatlich
-7.37%
Jährlich
-14.43%
Q2 Prognose
200.76




Nettoeinkommen Veränderung Datum
Ansell USD 88.8M 65.5M 2025-12
Artivion USD 2.42M 4.07M 2025-12
AtriCure USD 108K 1.65M 2026-03
Baxter International USD -15M 1.11B 2026-03
Cochlear AUD 161.5M 69.6M 2025-12
Cooper Companies USD 130.8M 46.2M 2025-12
CSL USD 401M 96.5M 2025-12
Dexcom USD 199.5M 67.8M 2026-03
Edwards Lifesciences USD 380.7M 289.5M 2026-03
Fisher Paykel Healthcare NZD 213M 11M 2025-12
Globus Medical USD 140.59M 21.63M 2025-12
Haemonetics USD 44.74M 6.06M 2025-12
Idexx Laboratories USD 278.45M 30.26M 2026-03
Inogen USD -5.96M 373K 2024-09
Insulet USD 91.1M 10.5M 2026-03
Integra LifeSciences USD -4.62M 2.91M 2026-03
Intuitive Surgical USD 821.5M 26.7M 2026-03
Masimo USD 68.3M 168.7M 2025-12
Medtronic USD 1.14B 231M 2025-12
Philips EUR 151M 244M 2026-03
Ramsay Health Care AUD 152.7M 32.4M 2025-12
ResMed USD 398.73M 6.14M 2026-03
Sigma Healthcare AUD -6.72M 10.02M 2024-12
Sonic Healthcare AUD 236.68M 82.29M 2024-12
Steris USD 192.9M 1000K 2025-12
Teleflex USD -714.33M 305.44M 2025-12
Thermo Fisher Scientific USD 1.65B 313M 2026-03